UROPLASTY INC-NEW
UPI
UPI was delisted on the 31st of March, 2015.
34 hedge funds and large institutions have $39.3M invested in UROPLASTY INC-NEW in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
56% more capital invested
Capital invested by funds: $25.1M → $39.3M (+$14.2M)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
17% more funds holding
Funds holding: 29 → 34 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
+$639K |
| 2 |
RCP
Rothschild Capital Partners
New York
|
+$423K |
| 3 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$212K |
| 4 |
Renaissance Technologies
New York
|
+$71.8K |
| 5 |
VAM
Visium Asset Management
New York
|
+$41.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$755K |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$545K |
| 3 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
-$534K |
| 4 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$274K |
| 5 |
BA
Bard Associates
Chicago,
Illinois
|
-$17.3K |
UPI Hedge Fund Activity: Q3 2013 in Review
34 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in UROPLASTY INC-NEW (UPI) for Q3 2013, worth a combined $39.3M — up 56% from $25.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new UPI positions and 1 closed out — a net gain of 5 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Sophrosyne Capital, opening a new position worth an estimated $639K. The largest seller was Manatuck Hill Partners, cutting an estimated $755K.
- 34 institutional investors held UROPLASTY INC-NEW (UPI) as of Q3 2013, up from 29 in Q2 2013.
- Funds reported $39.3M of UROPLASTY INC-NEW stock for Q3 2013, up 56% quarter-over-quarter.
- 6 funds opened new UROPLASTY INC-NEW positions in Q3 2013 and 1 closed out, a net change of +5 holders.
- The largest UROPLASTY INC-NEW buyer in Q3 2013 was Sophrosyne Capital, an estimated $639K added.
- The largest UROPLASTY INC-NEW seller in Q3 2013 was Manatuck Hill Partners, an estimated $755K sold.
Based on aggregated 13F filings for Q3 2013.